Initial entry criteria for the previous 2 double-blind clinical trials required that patients aged 18 years met the American College of Rheumatology 1990 criteria for FM , had a body mass index ( BMI ) < 40 kg/m2 , and had a score 50 on a 100-mm pain visual analog scale ( VAS ) at baseline .